Adenovirus is the most effective vector for in vivo gene delivery to the synovium, while retroviruses are better suited for ex vivo applications.
No takes yet. Share an insight, caveat, or question.
Informs vector selection for preclinical arthritis gene therapy models; leaves open clinical translation.
Nita et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: